Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-05-17
2005-05-17
Fredman, Jeffrey (Department: 1637)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S005000, C435S006120, C536S024300
Reexamination Certificate
active
06894152
ABSTRACT:
This invention is in the field of lymphadenopathy virus which has been designated Human Immunodeficiency Virus Type 1 (HIV-1). This invention relates to a diagnostic means and method to detect the presence of DNA, RNA or antibodies of the lymphadenopathy retrovirus associated with the acquired immune deficiency syndrome or of the lymphadenopathy syndrome by the use of DNA fragments of the peptides encoded by said DNA fragments. The invention further relates to the DNA fragments, vectors comprising them and the proteins expressed.
REFERENCES:
patent: 4520113 (1985-05-01), Gallo et al.
patent: 4629783 (1986-12-01), Cosand
patent: 4677054 (1987-06-01), White et al.
patent: 4708818 (1987-11-01), Montagnier et al.
patent: 4725669 (1988-02-01), Essex et al.
patent: 4808536 (1989-02-01), Chang et al.
patent: 5156949 (1992-10-01), Luciw et al.
patent: 6001977 (1999-12-01), Chang et al.
patent: 0 113 078 (1984-07-01), None
patent: 0 115 459 (1984-08-01), None
patent: 0 199 301 (1986-10-01), None
patent: 0 258 404 (1988-03-01), None
patent: 0245459 (1993-09-01), None
patent: WO 8404327 (1984-11-01), None
patent: WO 8705399 (1987-09-01), None
patent: WO 9104051 (1991-04-01), None
Richterich, Peter, “Estimation of errors in ‘Raw’ DNA sequences: a validation study”, Genome Research (1998) 8:251-259.*
Sch üpbach et al., “Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS,”Science, 224, 503-505 (1984).
Kalyanaraman et al., “Antibodies to the Core Protein of Lymphadenopathy-Associated Virus (LAV) in Patients with AIDS,”Science, 225, 321-323 (1984).
Robey et al., “Characterization of Envelope and Core Structural Gene Products of HTLB-III with Sera from AIDS Patients,”Science, 28, 593-595 (1985).
Allan et al., “Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-III,”Science, 228, 1091-1094 (1985).
Crowl et al., “HTLV-III Env Gene Products Synthesized inE. coliare Recognized by Antibodies Present in the Sera of AIDS Patients,”Chemical Abstracts, 103, p. 190, No. 154983e (1985).
Montagnier et al., “Identification and Antigenicity of the Major Envelope Glycoprotien of Lymphadenopathy-Associated Virus,”Chemical Abstracts, 103, p. 263, No. 34641v (1985).
Weiss et al., “Neutralization of Human T-lymphotropic Virus Type III by Sera of AIDS and AIDS-Risk Patients,”Nature, 316, 69-72 (1985).
Barin et al., “Virus Envelope Protein of HTLV-III Represents Major Target Antigen for Antibodies in AIDS Patients,”Science, 228, 1094-1096 (1985).
Wain-Hobson et al., “Nucleotide Sequence of the AIDS Virus, LAV,”Cell, 40, 9-17 (1985).
Muesing et al., “Nucleic Acid Structure and Expressiong of the Human AIDS/Lymphadenopathy Retrovirus,”Nature, 313, 450-458 (1985).
Schneider et al., “A Glycopolypeptide (gp 100) is the Main Antigen Detected by HTLV-III Antiserums,”Chemical Abstracts, 103, p. 430, No. 52370k (1985).
Sarngadharan et al., “Immunological Properties of HTLV-III Antigens Recognized by Sera of Patients with AIDS and AIDS-Related Complex and of Asymptomatic Carriers of HTLV-III Infection,”Chemical Abstracts, 103, p. 551, No. 121329t (1985).
Alizon et al., “Molecular Cloning of Lymphadenopathy-Associated Virus,”Nature, 312, 757-760 (1984).
Chang et al., “An HTLV-III Peptide Produced by Recombinant DNA is Immunoreactive With Sera From Patients With AIDS,”Nature, 315, 151-154 (1985).
Chang et al., “Detection of Antibodies to Human T-Cell Lymphotropic Virus-III (HTLV-III) with an Immunoassay Employing a RecombinantEscherichia coli-Derived Virual Antigenic Peptide,”Biotechnology, 3, 905-909 (1985).
Ratner et al., “Complete Nucleotide Sequence of the AIDS Virus, HTLV-III,”Nature, 313, 277-284 (1985).
Dreesman et al., “Antibody to Hepatitis B Surface Antigen After a Single Inoculation of Uncoupled Synthetic HBsAg Peptides,”Nature, 295, 158-160 (1982).
Kitchen et al., “Aetiology of AIDS-Antibodies to Human T-Cell Leukaemia Virus (Type III) in Haemophiliacs,”Nature, 312, 367-369 (1984).
Essex et al., “Antibodies to Cell Membrane Antigens Associated with Human T-Cell Leukemia Virus in Patients with AIDS,”Science, 220, 859-862 (1983).
Seiki et al., “Human Adult T-Cell Leukemia Virus: Complete Nucleotide Sequence of the Provirus Genome Integrated in Leukemia Cell DNA,”Proc. Natl. Acad. Sci.,USA,80, 3618-3622 (1983).
“Centocor Unveils R-DNA AIDS Assay; Faces FDA,”Biotechnol. Newswatch, vol. 5, p. 3, Abstract No. 03-10-003226 (1985).
Arya et al., “Homology of Genome of AIDS-Associated Virus With Genomes of Human T-Cell Leukemia Viruses,”Science, 225, 927-930 (1984).
Alizon Marc
Danos Oliver
Sonigo Pierre
Stewart Cole
Wain-Hobson Simon
Centre National de la Recherche Scientifique
Fredman Jeffrey
Institut Pasteur
LandOfFree
Cloned DNA sequences related to the genomic RNA of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloned DNA sequences related to the genomic RNA of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloned DNA sequences related to the genomic RNA of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3441187